291 related articles for article (PubMed ID: 32303225)
1. Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectiveness.
Ruiz-Limon P; Ladehesa-Pineda ML; Castro-Villegas MDC; Abalos-Aguilera MDC; Lopez-Medina C; Lopez-Pedrera C; Barbarroja N; Espejo-Peralbo D; Gonzalez-Reyes JA; Villalba JM; Perez-Sanchez C; Escudero-Contreras A; Collantes-Estevez E; Font-Ugalde P; Jimenez-Gomez Y
J Biomed Sci; 2020 Apr; 27(1):54. PubMed ID: 32303225
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients.
Pérez-Sánchez C; Ruiz-Limón P; Aguirre MA; Jiménez-Gómez Y; Arias-de la Rosa I; Ábalos-Aguilera MC; Rodriguez-Ariza A; Castro-Villegas MC; Ortega-Castro R; Segui P; Martinez C; Gonzalez-Conejero R; Rodríguez-López S; Gonzalez-Reyes JA; Villalba JM; Collantes-Estévez E; Escudero A; Barbarroja N; López-Pedrera C
J Autoimmun; 2017 Aug; 82():31-40. PubMed ID: 28465139
[TBL] [Abstract][Full Text] [Related]
3. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility.
Sur Chowdhury C; Giaglis S; Walker UA; Buser A; Hahn S; Hasler P
Arthritis Res Ther; 2014 Jun; 16(3):R122. PubMed ID: 24928093
[TBL] [Abstract][Full Text] [Related]
4. Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study.
Lubrano E; Perrotta FM; Marchesoni A; D'Angelo S; Ramonda R; Addimanda O; Olivieri I; Punzi L; Salvarani C
J Rheumatol; 2015 Feb; 42(2):258-63. PubMed ID: 25512483
[TBL] [Abstract][Full Text] [Related]
5. Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics.
Sieper J; Rudwaleit M; Lenaerts J; Wollenhaupt J; Myasoutova L; Park SH; Song YW; Yao R; Huyck S; Govoni M; Chitkara D; Vastesaeger N
Rheumatology (Oxford); 2016 Nov; 55(11):1946-1953. PubMed ID: 27411482
[TBL] [Abstract][Full Text] [Related]
6. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
Wallman JK; Kapetanovic MC; Petersson IF; Geborek P; Kristensen LE
Arthritis Res Ther; 2015 Dec; 17():378. PubMed ID: 26703005
[TBL] [Abstract][Full Text] [Related]
7. Work disability in non-radiographic axial spondyloarthritis patients before and after start of anti-TNF therapy: a population-based regional cohort study from southern Sweden.
Wallman JK; Jöud A; Olofsson T; Jacobsson LTH; Bliddal H; Kristensen LE
Rheumatology (Oxford); 2017 May; 56(5):716-724. PubMed ID: 28064208
[TBL] [Abstract][Full Text] [Related]
8. Circulating cell-free DNA correlate to disease activity and treatment response of patients with radiographic axial spondyloarthritis.
Peng Y; Wu Y; Chen S; Liu Y; Qian H; He Y; Huang H; Cai M; Liu W; Shi G
Sci Rep; 2024 Jan; 14(1):178. PubMed ID: 38168507
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study.
Andreasen RA; Kristensen LE; Ellingsen T; Christensen R; Baraliakos X; Wied J; Aalykke C; Ulstrup T; Schiøttz-Christensen B; Horn HC; Emamifar A; Duerlund B; Fischer L; Hansen IMJ
BMJ Open; 2017 Jul; 7(7):e015536. PubMed ID: 28698330
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological management of axial spondyloarthritis in adults.
Toussirot E
Expert Opin Pharmacother; 2019 Aug; 20(12):1483-1491. PubMed ID: 31095430
[No Abstract] [Full Text] [Related]
11. Certolizumab pegol for treating axial spondyloarthritis.
Desmarais J; Beier S; Deodhar A
Expert Opin Biol Ther; 2016 Aug; 16(8):1059-64. PubMed ID: 27366922
[TBL] [Abstract][Full Text] [Related]
12. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
Deodhar A; Strand V; Kay J; Braun J
Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
[TBL] [Abstract][Full Text] [Related]
13. Presence of subclinical inflammation in axial spondyloarthritis patients with NSAID/anti-TNF-α drug-induced clinical remission.
Zong HX; Xu SQ; Wang JX; Chu YR; Chen KM; Wang C; Tong WQ; Wang XL
Clin Rheumatol; 2022 May; 41(5):1403-1412. PubMed ID: 35083561
[TBL] [Abstract][Full Text] [Related]
14. Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohort.
Ciurea A; Weber U; Stekhoven D; Scherer A; Tamborrini G; Bernhard J; Toniolo M; Villiger PM; Zufferey P; Kissling RO; Michel BA; Exer P;
J Rheumatol; 2015 Jan; 42(1):101-5. PubMed ID: 25362654
[TBL] [Abstract][Full Text] [Related]
15. Treatment challenges in axial spondylarthritis and future directions.
Sieper J
Curr Rheumatol Rep; 2013 Sep; 15(9):356. PubMed ID: 23888365
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective Study.
Lubrano E; Massimo Perrotta F; Manara M; D'Angelo S; Addimanda O; Ramonda R; Punzi L; Olivieri I; Salvarani C; Marchesoni A
J Rheumatol; 2016 Aug; 43(8):1541-6. PubMed ID: 27252428
[TBL] [Abstract][Full Text] [Related]
17. Nicotine drives neutrophil extracellular traps formation and accelerates collagen-induced arthritis.
Lee J; Luria A; Rhodes C; Raghu H; Lingampalli N; Sharpe O; Rada B; Sohn DH; Robinson WH; Sokolove J
Rheumatology (Oxford); 2017 Apr; 56(4):644-653. PubMed ID: 28013195
[TBL] [Abstract][Full Text] [Related]
18. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
van der Heijde D; Dougados M; Landewé R; Sieper J; Maksymowych WP; Rudwaleit M; Van den Bosch F; Braun J; Mease PJ; Kivitz AJ; Walsh J; Davies O; Bauer L; Hoepken B; Peterson L; Deodhar A
Rheumatology (Oxford); 2017 Sep; 56(9):1498-1509. PubMed ID: 28498975
[TBL] [Abstract][Full Text] [Related]
19. Potential Role and Impact of Peripheral Blood Mononuclear Cells in Radiographic Axial Spondyloarthritis-Associated Endothelial Dysfunction.
Ruiz-Limon P; Ladehesa-Pineda ML; Lopez-Medina C; Lopez-Pedrera C; Abalos-Aguilera MC; Barbarroja N; Arias-Quiros I; Perez-Sanchez C; Arias-de la Rosa I; Ortega-Castro R; Escudero-Contreras A; Collantes-Estevez E; Jimenez-Gomez Y
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34199950
[TBL] [Abstract][Full Text] [Related]
20. The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis.
Atas N; Çakır B; Bakır F; Uçar M; Satış H; Güz GT; Demirel KD; Babaoğlu H; Salman RB; Güler AA; Karadeniz H; Haznedaroğlu Ş; Göker B; Öztürk MA; Tufan A
Clin Rheumatol; 2022 May; 41(5):1381-1389. PubMed ID: 35059881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
